Alimentary 'green' proteins as electrospun scaffolds for skin regenerative engineering

Journal of Tissue Engineering and Regenerative Medicine

Volumn 7, Issue 12, 2013, Pages 994-1008

  Lin, Leko ^a   Perets, Anat ^a   Har el, Yah el ^a   Varma, Devika ^a   Li, Mengyan ^a   Lazarovici, Philip ^b   Woerdeman, Dara L ^c   Lelkes, Peter I ^a  

^a DREXEL UNIVERSITY   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c R and D Green Materials LLC   (United States)

Author keywords

Electrospinning; Fibroblast; Gene expression; In vitro; Scaffold; Soy protein; Wound healing; Zein

Indexed keywords

ADHESION; CELL CULTURE; COLLAGEN; ETHYLENE; FIBROBLASTS; POLYETHYLENE OXIDES; POLYMERASE CHAIN REACTION; SCAFFOLDS (BIOLOGY); SUBSTRATES; TISSUE REGENERATION;

ELECTROSPUN SCAFFOLDS; ELECTROSPUNS; FIBROBLAST; GENES EXPRESSION; IN-VITRO; SKIN SUBSTITUTES; SOY PROTEIN; SOY PROTEIN ISOLATES; WOUND DRESSINGS; WOUND HEALING;

GENE EXPRESSION;

COLLAGEN TYPE 1; COLLAGEN TYPE 7; INTERSTITIAL COLLAGENASE; LAMININ; LAMININ BETA3; SOYBEAN PROTEIN; STROMELYSIN 2; UNCLASSIFIED DRUG; ZEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ELECTROSPINNING; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGENERATIVE MEDICINE; SKIN; TISSUE ENGINEERING; TISSUE REGENERATION; WOUND DRESSING; WOUND HEALING;

ELECTROSPINNING; FIBROBLAST; GENE EXPRESSION; IN VITRO; SCAFFOLD; SOY PROTEIN; WOUND HEALING; ZEIN;

CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN TYPE I; DERMIS; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; MALE; MATERIALS TESTING; POLYETHYLENE GLYCOLS; REGENERATION; REGENERATIVE MEDICINE; SKIN; SOYBEAN PROTEINS; TENSILE STRENGTH; TIME FACTORS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; ZEIN;

EID: 84888435073     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1493     Document Type: Article

References (81)

1. Adekogbe I, Ghanem A. 2005; Fabrication and characterization of DTBP-crosslinked chitosan scaffolds for skin tissue engineering. Biomaterials 26: 7241-7250.
2. Armstrong WB, Wan XS, Kennedy AR, et al. 2003; Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment. Laryngoscope 113: 1687-1702.
3. Barnes CP, Smith MJ, Bowlin GL, et al. 2006; Feasibility of electrospinning the globular proteins hemogloblin and myoglobin. J Eng Fibers Fabrics 1: 16-28.
4. Bhardwaj N, Kundu SC. 2010; Electrospinning: a fascinating fiber fabrication technique. Biotechnol Adv 28: 325-347.
5. Chen L, Hébrard G, Beyssac E, et al. 2010a; In vitro study of the release properties of soy-zein protein microspheres with a dynamic artificial digestive system. J Agric Food Chem 58: 9861-9867.
6. Chen H, Huang J, Yu J, et al. 2010b; Electrospun chitosan-graft-poly(ε-caprolactone)/poly(ε-caprolactone) cationic nanofibrous mats as potential scaffolds for skin tissue engineering. Int J Biol Macromol 48: 13-19.
7. Curt S, Subirade M, Rouabhia M. 2009; Production and in vitro evaluation of soy protein-based biofilms as a support for human keratinocyte and fibroblast culture. Tissue Eng Part A 15: 1223-1232.
8. de Lumen BO. 2005; Lunasin: a cancer-preventive soy peptide. Nutr Rev 63: 16-21.
9. Diridollou S, Patat F, Gens F, et al. 2000; In vivo model of the mechanical properties of the human skin under suction. Skin Res Tech 6: 214-221.
10. Enoch S, Shaaban H, Dunn KW. 2005; Informed consent should be obtained from patients to use products (skin substitutes) and dressings containing biological material. J Med Ethics 31: 2-6.
11. Fisher GJ, Quan T, Purohit T, et al. 2009; Collagen fragmentation promotes oxidative stress and elevates matrix metalloproteinase-1 in fibroblasts in aged human skin. Am J Pathol 174: 101-114.
12. Fonder MA, Lazarus GS, Cowan DA, et al. 2008; Treating the chronic wound: a practical approach to the care of nonhealing wounds and wound care dressings. J Am Acad Dermatol 58: 185-206.
13. Fung WY, Yuen KH, Liong MT. 2010; Characterization of fibrous residues from agrowastes and the production of nanofibers. J Agric Food Chem 58: 8077-8084.
14. Ghanaati S, Fuchs S, Webber MJ, et al. 2011; Rapid vascularization of starch-poly(caprolactone) in vivo by outgrowth endothelial cells in co-culture with primary osteoblasts. J Tissue Eng Regen Med 5: e136-e143.
15. Gong S, Wang H, Sun Q, et al. 2006; Mechanical properties and in vitro biocompatibility of porous zein scaffolds. Biomaterials 27: 3793-3799.
16. Guo Y, Li M, Mylonakis A, et al. 2007; Electroactive oligoaniline-containing self-assembled monolayers for tissue engineering applications. Biomacromolecules 8: 3025-3034.
17. Han J, Lazarovici P, Pomerantz C, et al. 2011; Co-electrospun blends of PLGA, gelatin, and elastin as potential nonthrombogenic scaffolds for vascular tissue engineering. Biomacromolecules 12: 399-408; DOI: 10.1021/bm101149r.
18. Hua Y, Yuang Y, Qiu A, et al. 2005; Properties of soy protein isolate prepared from aqueous alcohol washed soy flakes. Food Res Int 38: 273-279.
19. Figallo E, Flaibani M, Zavan B, et al. 2007; Micropatterned biopolymer 3D scaffold for static and dynamic culture of human fibroblasts. Biotechnol Prog 23: 210-216.
20. Jeong L, Yeo IS, Kim HN, et al. 2009; Plasma-treated silk fibroin nanofibers for skin regeneration. Int J Biol Macromol 44: 222-228.
21. Jiang Y, Tang C-H, Wen Q-B, et al. 2007a; Effect of processing parameters on the properties of transglutaminase-treated soy protein isolate films. Innovat Food Sci Emerg Tech 8: 218-225.
22. Jiang H, Zhao P, Zhu K. 2007b; Fabrication and characterization of zein-based nanofibrous scaffolds by an electrospinning method. Macromol Biosci 7: 517-525.
23. Koombhongse S, Liu W, Reneker DH. 2001; Flat polymer ribbons and other shapes by electrospinning. J Polymer Sci B Polymer Phys 39: 2598-2606.
24. Kuipers BJ, Gruppen H. 2008; Identification of strong aggregating regions in soy glycinin upon enzymatic hydrolysis. J Agric Food Chem 56: 3818-3827.
25. Lelkes PI, Li M, Perets A, et al. 2008; Electrospinning of natural proteins for tissue engineering scaffolding. In Handbook of Natural-based Polymers for Biomedical Applications, Reis RL (ed.). Woodhead: Cambridge, UK; 446-482.
26. Li M, Mondrinos MJ, Gandhi MR, et al. 2005; Electrospun protein fibers as matrices for tissue engineering. Biomaterials 26: 5999-6008.
27. Li M, Guo Y, Wei Y, et al. 2006; Electrospinning polyaniline-contained gelatin nanofibers for tissue engineering applications. Biomaterials 27: 2705-2715.
28. Luo LH, Zhang YF, Wang XM, et al. 2010; Preparation, characterization, and in vitro and in vivo evaluation of cellulose/soy protein isolate composite sponges. J Biomater Appl 24: 503-526.
29. Lv M-Y, Ge H-Y, Chen J. 2009; Study on the chemical structure and skin-core structure of polyacrylonitrile-based fibers during stabilization. J Polym Res 16: 513-517.
30. Mallikarjun Gouda KG, Gowda LR, Rao AG, et al. 2006; Angiotensin I-converting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max). J Agric Food Chem 54: 4568-4573.
31. Maltais A, Remondetto GE, Subirade M. 2007; Mechanisms involved in the formation and structure of soya protein cold-set gels: a molecular and supramolecular investigation. Food Hydrocolloids 22: 550-559.
32. Maruyama N, Maruyama Y, Tsuruki T, et al. 2003; Creation of soybean β-conglycinin-β with strong phagocytosis-stimulating activity. Biochim Biophys Acta 1648: 99-104.
33. Mauri AN, Añon MC. 2006; Effect of solution pH on solubility and some structural properties of soybean protein isolate films. J Sci Food Agric 86: 1064-1072.
34. Medina A, Ghaffari A, Kilani RT, et al. 2007; The role of stratifin in fibroblast-keratinocyte interaction. Mol Cell Biochem 305: 255-264.
35. Medina A, Ghahary A. 2010; Fibrocytes can be reprogrammed to promote tissue remodeling capacity of dermal fibroblasts. Mol Cell Biochem 344: 11-21.
36. Metcalfe AD, Ferguson MW. 2007; Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. J R Soc Interface 4: 413-437.
37. Min B-M, Lee G, Kim SH, et al. 2004; Electrospinning of silk fibroin nanofibers and its effects on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro. Biomaterials 25: 1289-1297.
38. Miyoshi S, Ishikawa H, Kaneko T, et al. 1991; Structures and activity of angiotensin-converting enzyme inhibitors in an α-zein hydrolysate. Agric Biol Chem 55: 1313-1318.
39. Mizutani Y, Matsumura Y, Imamura K, et al. 2003; Effects of water activity and lipid addition on secondary structure of zein in powder systems. J Agric Food Chem 51: 229-235.
40. Morihara K, Takai S, Takenaka H, et al. 2006; Cutaneous tissue angiotensin-converting enzyme may participate in pathologic scar formation in human skin. J Am Acad Dermatol 54: 251-257.
41. Nielsen NC. 1985; Structure of soy proteins. In New Protein Foods, vol 5, Altschul AA, Wilcke HL (eds). Academic Press: New York; 27-64.
42. Nikolaychik VV, Samet MM, Lelkes PI. 1996; A new method for continual quantitation of viable cells on endothelialized polyurethanes. J Biomater Sci Polym Ed 7: 881-891.
43. Noszczyk BH, Klein E, Holtkoetter O, et al. 2002; Integrin expression in the dermis during scar formation in humans. Exp Dermatol 11: 311-318.
44. Pardo A, Selman M. 2005; MMP-1: the elder of the family. Int J Biochem Cell Biol 37: 283-288.
45. Powell HM, Boyce ST. 2007; Fiber density of electrospun gelatin scaffolds regulates morphogenesis of dermal-epidermal skin substitutes. J Biomed Mater Res A 84: 1078-1086.
46. Powell HM, Supp DM, Boyce ST. 2008; Influence of electrospun collagen on wound contraction of engineered skin substitutes. Biomaterials 29: 834-843.
47. Reddy N, Yang Y. 2009; Soyprotein fibers with high strength and water stability for potential medical applications. Biotechnol Prog 25: 1796-1802.
48. Rnjak J, Li Z, Maitz PK, et al. 2009; Primary human dermal fibroblast interactions with open weave three-dimensional scaffolds prepared from synthetic human elastin. Biomaterials 30: 6469-6477.
49. Rnjak J, Wise SG, Mithieux SM, et al. 2011; Severe burn injuries and the role of elastin in the design of dermal substitutes. Tissue Eng Part B Rev 17: 81-91.
50. Rnjak-Kovacina J, Wise SG, Li Z, et al. 2011; Tailoring the porosity and pore size of electrospun synthetic human elastin scaffolds for dermal tissue engineering. Biomaterials 32: 6729-6736.
51. Saeed AI, Bhagabati NK, Braisted JC, et al. 2006; TM4 microarray software suite. Methods Enzymol 411: 134-193.
52. Salmela MT, Pender SL, Karjalainen-Lindsberg ML, et al. 2004; Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing. Scand J Gastroenterol 39: 1095-1104.
53. Santos MI, Fuchs S, Gomes ME, et al. 2007; Response of micro- and macrovascular endothelial cells to starch-based fiber meshes for bone tissue engineering. Biomaterials 28: 240-248.
54. Santos MI, Tuzlakoglu K, Fuchs S, et al. 2008; Endothelial cell colonization and angiogenic potential of combined nano- and micro-fibrous scaffolds for bone tissue engineering. Biomaterials 29: 4306-4313.
55. Scuderi N, Anniboletti T, Carlesimo B, et al. 2009; Clinical application of autologous three-cellular cultured skin substitutes based on esterified hyaluronic acid scaffold: our experience. In Vivo 23: 991-1003.
56. Selling GW, Biswas A, Patel A, et al. 2007; Impact of solvent on electrospinning of zein and analysis of resulting fibers. Macromol Chem Phys 208: 1002-1010.
57. Shenoy SL, Bates WD, Frisch HL, et al. 2005; Role of chain entanglements on fiber formation during electrospinning of polymer solutions: good solvent, non-specific polymer-polymer interaction limit. Polymer 46: 3372-3384.
58. Shukla R, Cheryan M. 2001; Zein: the industrial protein from corn. Ind Crop Prod 13: 171-192.
59. Silva GA, Vaz CM, Coutinho OP, et al. 2003; In vitro degradation and cytocompatibility evaluation of novel soy and sodium caseinate-based membrane biomaterials. J Mater Sci Mater Med 14: 1055-1066.
60. Silva SS, Santos MI, Coutinho OP, et al. 2005; Physical properties and biocompatibility of chitosan/soy blended membranes. J Mater Sci Mater Med 16: 575-579.
61. Sirén V, Salmenperä P, Kankuri E, et al. 2006; Cell-cell contact activation of fibroblasts increases the expression of matrix metalloproteinases. Ann Med 38: 212-220.
62. Soliman S, Sant S, Nichol JW, et al. 2011; Controlling the porosity of fibrous scaffolds by modulating the fiber diameter and packing density. J Biomed Mater Res A 96: 566-574.
63. Sun QS, Dong J, Lin ZX, et al. 2005; Comparison of cytocompatibility of zein film with other biomaterials and its degradability in vitro. Biopolymers 78: 268-274.
64. Tian K, Shao Z, Chen X. 2010; Natural electroactive hydrogel from soy protein isolation. Biomacromolecules 11: 3638-3643.
65. Tu J, Wang H, Li H, et al. 2009; The in vivo bone formation by mesenchymal stem cells in zein scaffolds. Biomaterials 30: 4369-4376.
66. Tuzlakoglu K, Bolgen N, Salgado AJ, et al. 2005; Nano- and microfiber combined scaffolds: a new architecture for bone tissue engineering. J Mater Sci Mater Med, 16: 1099-1104.
67. van der Valk P, van Pelt AW, Busscher HJ, et al. 1983; Interaction of fibroblasts and polymer surfaces: relationship between surface free energy and fibroblast spreading. J Biomed Mater Res 17: 807-817.
68. Vaz CM, De Graaf LA, Reis RL, et al. 2003a; Effect of crosslinking, thermal treatment and UV irradiation on the mechanical properties and in vitro degradation behavior of several natural proteins aimed to be used in the biomedical field. J Mater Sci Mater Med 14: 789-796.
69. Vaz CM, De Graaf LA, Reis RL, et al. 2003b; In vitro degradation behaviour of biodegradable soy plastics: effects of crosslinking with glyoxal and thermal treatment. Polymer Degrad Stabil 81: 65-74.
70. Vaz CM, van Doeveren PF, Reis RL, et al. 2003c; Soy matrix drug delivery systems obtained by melt-processing techniques. Biomacromolecules 4: 1520-1529.
71. Vaz CM, van Doeveren PF, Dias GR, et al. 2004; Controlled delivery achieved with bilayer matrix devices produced by co-injection moulding. Macromol Biosci 4: 795-801.
72. Vega-Lugo A, Lim L. 2008; Electrospinning of soy protein isolate nanofibers. J Biobased Mater Bioenerg, 2: 223-230.
73. Wang HJ, Gong SJ, Lin ZX, et al. 2007; In vivo biocompatibility and mechanical properties of porous zein scaffolds. Biomaterials 28: 3952-3964.
74. Wang Q, Zheng YP. 2009; Ultrasound biomicroscopy imaging for monitoring progressive trypsin digestion and inhibition in articular cartilage. Ultrasound Med Biol 35: 1535-1545.
75. Woerdeman DL, Ye P, Shenoy S, et al. 2005; Electrospun fibers from wheat protein: investigation of the interplay between molecular structure and the fluid dynamics of the electrospinning process. Biomacromolecules 6: 707-712.
76. Wong T, Gammon L, Liu L, et al. 2008; Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 128: 2179-2189.
77. Woodley DT, Remington J, Huang Y, et al. 2007; Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing. Mol Ther 15: 628-635.
78. Xu YZ, Wu JJ, Chen YP, et al. 2010; The use of zein and Shuanghuangbu for periodontal tissue engineering. Int J Oral Sci 2: 142-148.
79. Yao C, Li X, Song T. 2007; Electrospinning and crosslinking of zein nanofiber mats. J Appl Polymer Sci 103: 380-385.
80. Zhang X, Min BG, Kumar S. 2003; Solution spinning and characterization of poly(vinyl alcohol)/soybean protein blend fibers. J Appl Polymer Sci 90: 716-721.
81. Znoyko I, Trojanowska M, Reuben A. 2006; Collagen binding α2β1 and α1β1 integrins play contrasting roles in regulation of Ets-1 expression in human liver myofibroblasts. Mol Cell Biochem 282: 89-99.